[Long-term survivals in lymphomas and generalized lymphosarcomas treated by chemo- and hormonal therapy].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004357:Drug Synergism; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D008136:Longevity; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D014265:Triethylenemelamine / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D006834:Hydrazines; D009588:Nitrogen Mustard Compounds; D014747:Vinblastine; D003520:Cyclophosphamide; D014265:Triethylenemelamine; D011241:Prednisone
Longues survies de lymphomes et de lymphosarcomes généralises traités par chimio- et hormonothérapie.